The evolution of the disability-adjusted life year (DALY)

https://doi.org/10.1016/j.seps.2014.12.002Get rights and content

Highlights

  • We review the methodological progression of the DALY, a summary health measure.

  • Changes in the DALY components have improved the DALY metric.

  • Component changes make it difficult to interpret, compare, and conduct DALY studies.

Abstract

The disability-adjusted life year (DALY) is a summary health measure that combines mortality and morbidity into a single measure as a way to estimate global disease burden and the effectiveness of health interventions. We review the methodological progression of the DALY, focusing on how the use of life expectancy estimates, disability weights, age weighting, and discounting has evolved since the first DALY reports were published in 1993. These changes have generally improved the metric but have made it difficult for researchers to interpret, compare, and conduct DALY studies.

Introduction

The disability-adjusted life year (DALY) made waves in the international development community when it was introduced in the 1993 World Development Report [1]. Previous estimates of global burden of disease generally focused on mortality rates, both because reducing fatalities was a top public health priority and because deaths are easy to count [2]. However, mortality data alone are not sufficient for painting a picture of the state of health in a community, nation, or region. As mortality rates began to level off in industrialized nations toward the late twentieth century, researchers from a variety of disciplinary perspectives created new health metrics that incorporated physical and psychological morbidity and disability in addition to mortality, including the quality-adjusted life year (QALY) [3] and the healthy year equivalent (HYE) [4]. The DALY, which estimates the gap between a population's health status and an “ideal” level of health and survival, emerged as a commonly used tool. Economists, epidemiologists, and policy experts, especially those who work on health issues in low- and middle-income countries, frequently use the DALY for population health assessments, priority setting, and program evaluation. By contrast, decision scientists, health economists, and policymakers in high-income countries more frequently use the QALY metric.

The conceptual framework for the DALY uses the term “disability” to refer to any acute or chronic illness that reduces physical or mental health status in the short-term or the long-term. “Disabilities” in DALY models include conditions such as quadriplegia, total blindness, and developmental disorders as well as infectious and parasitic diseases, nutritional deficiencies, maternal and perinatal conditions, a diversity of non-communicable and neuropsychiatric conditions, and injuries. DALYs aim to quantify at the population level the total years of life lost to premature death and the years of life lived with suboptimal health due to any condition that reduces functioning partially or fully for a short period of time or a long duration.

While the underlying conceptual model for the DALY remains unchanged, the DALY has been under continuous revision since it was first developed by World Health Organization and World Bank collaborators in 1993 [1]. Major changes to DALY estimation methods were made for the Global Burden of Disease (GBD) estimates for 1990 [5], [6], [7], [8], [9] and 2010 [10], [11], [12], [13], [14], [15], [16]. In the intervening years, updated GBD estimates were published annually from 1999 to 2004, [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27] and several major regional European studies were published in the 2000s [28], [29], [30], [31]. DALY methods have also been used for cost-effectiveness analysis in low- and middle-income countries [32], [33], [34], [35]. DALYs represented a major step forward for population health metrics [36]. However, as researchers have tweaked the equations used for estimating the DALY and have challenged some of the assumptions underlying these calculations, comparing DALY estimates across time has become difficult.

All versions of the DALY quantify the burden of disease by combining mortality and morbidity in a single metric. The basic equation for the DALY is the sum of a population's years of the life lost (YLL) to premature death and the years lived with disability (YLD):DALY=YLL+YLD

The most basic equation for the YLLs lost in a population during a particular time period, such as one year, is:YLL=N×Lwhere N is the number of deaths in the population and L is the population's average remaining life expectancy, in years, at the age of death. The basic equation for YLDs in a population is:YLD=(I×L)×W=P×Wwhere I is the number of incident cases of a particular condition in the population, L is the average length (duration) of disability from a particular condition, P is the prevalence of the condition, and W is the disability weight associated with the condition.

However, neither YLLs nor YLDs can be directly measured. The YLL is dependent on the researcher's selection of the total years a member of the population is, on average, “expected” to live. The YLD depends on how disability weights are assigned for various health conditions or consequences. Additionally, some DALY models apply discounting and age weighting functions that generally apportion higher YLL and YLD values to current health problems and those that affect the young, and assign lower values to future health concerns and ones that primarily affect older adults. Thus, the number of DALYs estimated for a population may be vastly different depending on the assumptions made. Two research groups working with the same population data about births, deaths, incidence, and prevalence could arrive at very different sets of DALY estimates.

Most DALY estimates are derived from complex mathematical models that account for age distributions, population dynamics such as birth and age-specific death rates, and even socioeconomic strata. These more computationally intense approaches require more cumbersome equations. A discounted, age-weighted YLL can be calculated within a model by an equation such as this one [5]:YLL=KCera(r+β)2{e(r+β)(L+a)[(r+β)(L+a)1]e(r+β)a[(r+β)a1]}+1Kr(1erL)where K is an age weighting value, C is a constant that ensures that the total number of DALYs worldwide remains the same with and without age weighting, a is the age at death, r is the discount rate, β is a constant that adjusts the shape of the age weighting curve, and L is the standard expectation of remaining years of life at the time of death at age a. The expanded equation for YLD is similarly unwieldy [5].

These models require assumptions about life expectancy, disability weights for numerous causes of reduced health status, discount rates, and age weighting. Each of these assumptions requires careful consideration when attempting to estimate the DALYs in a population or interpreting reports of DALYs. This paper summarizes the evolution of the DALY, focusing on how the use of these four particular components has changed over time. Knowledge of the history of the DALY is a necessary foundation for calculating, interpreting, and comparing DALY estimates.

Section snippets

Life expectancy

Life expectancy in the DALY context is sometimes an “aspirational” target population value rather than one based solely on current metrics in the population being studied [5]. The WHO Guide to Cost-Effectiveness Analysis, published in 2003, outlined four different measures that could be used to estimate life expectancy for DALYs [37]. The simplest is a potential years of life lost (PYLL) approach in which a target population life expectancy is selected and used for all age groups. For example,

Disability weights

Disability weighting assigns a value between 0 and 1 that approximates the decrease in health and function associated with various illnesses and impairments. A weight of 0 indicates no disability; a weight of 1 indicates full disability equivalent to death [1]. In this context, “disability” refers to any state of diminished health, whether due to an acute or chronic infection, non-communicable disease, neuropsychiatric condition, injury, physical impairment, or any other cause [39].

Disability

Discounting

Discounting is an economic concept that assigns greater value to near-term benefits than ones that might accrue in the future. With discounting, an intervention that prevents 1000 cases of cancer this year will remove more DALYs from a population's total count of DALYs than an intervention expected to prevent 1000 cases of cancer from occurring 50 years from now. Discounting provides an incentive for policymakers and practitioners to focus on health interventions that can be implemented right

Age weighting

Age weighting may be used to increase or decrease the DALYs contributed by various age groups within a population if some age groups are deemed more “valuable” than others. When younger adults are expected to be significantly more economically productive than older adults, a disability in a younger adult can be considered more burdensome to a population than the exact same disability in an older adult. In 2006, Sassi identified age weighting as an important component that makes the DALY unique

Conclusions

Over the last two decades, the DALY has evolved from being a rough estimator of population health to a sophisticated summary measure of the local, regional, and global burden of disease. Life expectancy, which was based on the highest observed life expectancy in 1993, has been updated to be based on the lowest globally observed death rate at every age group. Disability weights set by panels of health experts have been replaced with rankings from large-scale population-based surveys from diverse

Contributors

All of the co-authors contributed to the preparation and critical revision of the manuscript.

Conflict of interest

The authors declare no conflicts of interest.

Acknowledgments

Ms. Chen was funded by the Beyond Traditional Borders Initiative, a grant to Rice University from the Howard Hughes Medical Institute. Dr. Cantor is funded, in part, from grant #AID-OAA-A-13-00014 from United States Agency for International Development (USAID). Additional support came from The University of Texas MD Anderson Cancer Center.

The authors wish to thank Jennifer M. Gatilao for editorial contributions that enhanced the quality of the manuscript.

Ariel Chen is a MD candidate at Baylor College of Medicine. She earned her bachelor's degree in Economics from Rice University in 2014 and was also a Beyond Traditional Borders Scholar sponsored by the Rice 360 Institute for Global Health Technologies.

References (57)

  • S.S. Lim et al.

    A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

    Lancet

    (2012)
  • E. Marseille et al.

    Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

    Lancet

    (1999)
  • C.J. Murray et al.

    Understanding DALYs (disability-adjusted life years)

    J Health Econ

    (1997)
  • C.J. Murray et al.

    GBD 2010: design, definitions, and metrics

    Lancet

    (2012)
  • J. Jelsma et al.

    The global burden of disease disability weights

    Lancet

    (2000)
  • K.C. James et al.

    Weighing up disability

    Lancet

    (1999)
  • T.B. Üstün et al.

    Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH joint project CAR study group

    Lancet

    (1999)
  • E. Nord

    Disability weights in the Global Burden of Disease Study 2010: unclear meaning and overstatement of international agreement

    Health Policy

    (2013)
  • S. Anand et al.

    Disability-adjusted life years: a critical review

    J Health Econ

    (1997)
  • World Bank

    World development report 1993: investing in health

    (1993)
  • M.R. Gold et al.

    HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health

    Annu Rev Public Health

    (2002)
  • C.J. Murray

    Quantifying the burden of disease: the technical basis for disability-adjusted life years

    Bull World Health Organ

    (1994)
  • A. Mehrez et al.

    Quality-adjusted life years, utility theory, and healthy-years equivalents

    Med Decis Making

    (1989)
  • C.J. Murray

    Rethinking DALYs

  • C.D. Mathers et al.

    Global Burden of Disease Study 2000: version 2 methods and results. Global programme on evidence for health policy discussion paper

    (2002)
  • C.D. Mathers et al.

    The burden of disease and mortality by condition: data, methods, and results for 2001

  • C.J.L. Murray et al.

    The Global Burden of Disease Study 2000 project: aims, methods and data sources

    (2001)
  • A.D. Lopez et al.

    Global burden of disease and risk factors

    (2006)
  • Cited by (0)

    Ariel Chen is a MD candidate at Baylor College of Medicine. She earned her bachelor's degree in Economics from Rice University in 2014 and was also a Beyond Traditional Borders Scholar sponsored by the Rice 360 Institute for Global Health Technologies.

    Kathryn H. Jacobsen MPH, PhD is an Associate Professor in the Department of Global & Community Health at George Mason University in Fairfax, Virginia. She is an epidemiologist who conducts research on global health and health transitions, the shifts in population disease burden that occur in conjunction with socioeconomic development.

    Ashish A. Deshmukh PhD, MPH is a Janice Davis Gordon postdoctoral fellow in the Department of Health Services Research at The University of Texas MD Anderson Cancer Center. He received his doctorate in health economics from The University of Texas Health Science Center School of Public Health. His research focuses on clinical and economic evaluation of cancer screening programs and treatments, risk prediction modelling, and value of conducting additional research.

    Scott B. Cantor PhD is a Professor in the Department of Health Services Research at The University of Texas MD Anderson Cancer Center. He also has adjunct appointments in the Departments of Biostatistics at The University of Texas Houston School of Public Health and in the Department of Statistics at Rice University, where he frequently guest lectures on decision analysis and economic evaluation of health care programs. Dr. Cantor’s research focuses on the theory of medical decision making and its application to problems in cancer prevention.

    1

    Rice University, Institute for Global Health Technologies, Houston, TX 77005, USA. Tel.: +503 298 1938.

    2

    Department of Global and Community Health, George Mason University, 4400 University Drive MS 5B7, Fairfax, VA 22030, USA. Tel.: +703 993 9168.

    3

    Department of Health Services Research – Unit 1444, The University of Texas MD Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, USA. Tel.: +713 563 0020.

    View full text